We have developed a new method of detecting islet cell antibodies using peroxidase-labeled protein A, and have determined the incidence of ICA in Type 1 (insulin-dependent) diabetes in Japan. In our method, fresh frozen sections of human pancreas and serum samples were incubated and then treated with peroxidase-labeled protein A at room temperature. Conjugates of peroxidase and protein A were subjected to Sephadex G-200 column chromatography, and only the 80,000 dalton peak was employed. The treated sections were allowed to react with haematoxylin and eosin (HE) to confirm the localization of islet cells. With this method, human pancreatic tissues can be used regardless of age and blood type, and the stained sections can be stored for more than 5 years. Serum samples obtained from 52 patients with Type 1 diabetes, 54 with Type 2 (non-insulin-dependent) diabetes and 100 control subjects were examined. In patients with Type 1 diabetes, islet cell antibodies were detected in 14 of 14 (0.5 years after onset), 3 of 6 (0.5-1 years after onset), 7 of 16 (1-5 years after onset) and 2 of 16 (more than 5 years after onset). In contrast, only 4 of 54 patients with Type 2 diabetes and none of the controls were 1CA positive. It is concluded that, with our newly developed method using peroxidaselabeled protein A, ICA is present in all Japanese Type I diabetic patients whose diabetic manifestations are less than 0.5 years duration from onset.
Islet cell antibodies (ICA) were first described in the sera of patients with polyendocrine disease, and almost all were associated with Type 1 (insulin-dependent) diabetes [1] [2] [3] [4] . However, ICA detection has not been widely used in clinical practice because an indirect immunofluorescence assay requires fresh human pancreas obtained from only young blood group 0 donors. These limiting prerequisites are due to nonspecific exocrine reactions on pancreatic sections from other blood groups. Therefore, investigations were undertaken to develop a new method of detecting ICA using human pancreas tissues regardless of age and blood type, and to determine the incidence of ICA in Japanese diabetic patients.
Subjects and methods

Subjects
Serum samples were obtained from 52 Type 1 diabetic patients, 54 Type 2 diabetic patients and 100 control subjects. All 52 patients with Type 1 diabetes had a history of having had at least one episode of ketoacidosis, and were being treated with insulin. The patients with Type I diabetes were divided into four groups according to the time when ICA was first assayed after onset of clinical manifestations: less than 0.5 years (14 patients), 0.5 1 years (6 patients), 1-5 years (16 patients) and > 5 years (16patients). In addition, in order to observe the interference of other autoantibodies, serum samples were obtained from 5 patients with systemic lupus erythematosus (positive antinuclear antibodies), 4 patients with primary biliary cirrhosis (positive mitochondrial antibodies) and 10patients with Hashimoto's disease (positive microsomal antibodies). Serum samples were stored at -20 °C until assayed.
Methods
ICA.
ICA was detected by an indirect immunofluorescence assay (IF) and immunochemical staining with peroxidase-labeled protein A (POPA). Tile IF method based on that of Roitt and Doniach [5] , previously described in detail [6] , was used. The immunochemical staining with POPA is as follows:
Horseradish peroxidase conjugation with protein A. Free protein A (Pharmacia, Uppsala, Sweden, 5 mg) was conjugated with horseradish peroxidase (Sigma, St. Louis, USA, type VI 5 rag) activated by 0.06 tool/1 NaIO4 for 30 min according to the method of Nakane and Kawaoi [7] and Engel et al. [8] . Chromatography was carried out on a 90 × 1.5 cm column of Sephadex G-200 with a flow rate of approximately 5 ml/h in order to separate into peroxidase-labeled protein A and non-bound peroxidase. The fractions in the first peak (80,000 dalton) were pooled and used for the determination of ICA.
POPA staining. Fresh frozen sections of the pancreas were washed with 0.01 mol/1 phosphate buffer saline (PBS) containing 2% bovine serum albumin (BSA) (pH 7.2). The pancreatic sections were applied with 50 p.l serum and incubated in a moist chamber at room temperature for 60 min. After incubation the sections were washed in PBS three times. The pancreatic sections were then rinsed with peroxidaselabeled protein A (20 ~g/ml, 50 ~tl) and incubated at room temperature for 30 rain. After being washed with PBS, they were stained with Karnovsky's diaminobenzidine solution [9] for 8 rain. The staining sections were washed, dehydrated with alcohol, plated and observed by light microscopy. In addition, the same sections were stained with haematoxylin and eosin (HE) to confirm a Langerhans islet.
Human pancreas. Normal human pancreata were obtained from 4 males (37, 62, 67, 74 years of age) and one female (52 years of age) with blood group 0, 2 females (53, 58years of age) and one male (68 years of age) with blood group A, one 42-year-old female with blood group B and one 55-year-old female with blood group AB. The ICA titres. The tCA titre was defined as the highest dilution of serum giving a positive stained reaction in both the IF and the POPA method.
Statistical analysis. Correlation coefficients were obtained using the Student's t-test.
Results
POPA method
Figure 1 A -E shows staining of pancreatic cryostat sections obtained from a blood group 0 37-year-old male donor (A and B), blood group A (C), B (D) and AB (E). When the sections were treated with ICA positive serum of a 13-year-old male patient with newly diagnosed Type 1 diabetes and stained by the POPA method, the Langerhans islet cells were stained brown (A). The area stained brown was confirmed as a Langerhans islet by additional staining with HE (B). POPA staining was also satisfactory in the cases of blood group A (C), group B (D) and group AB (E), respectively, when the pancreatic sections were treated with the same ICA positive serum.
I C A titres
The titre levels were defined as being the maximum dilution of serum giving a positive stain reaction. Comparison between IF method and POPA method Table 1 shows the results of determination of ICA using the IFmethod and the POPAmethod in 10 serum sam- 
Incidence of lCA in Japanese subjects
Studies were performed in 52 Type 1 diabetic patients, 54 Type 2 diabetic patients and 100 control subjects. As shown in Table 2 , 3 sera from Type I diabetic patients showed positive reaction only by the POPAmethod, and titres of these 3 sera were 1 x. One serum from a control subject showed positive staining only by the IF method. The reason of the difference between IF and the POPA method in this one control subject is unclear, since he had no other autoantibodies and he was not a relative of a diabetic patient. Figure 4 shows the results by the POPA method of 52Type 1 diabetic patients who were separated into four groups according to the duration after onset. ICA were detected in 100% (14/14) of patients with less than 0.5years duration, 50% (3/6) of 0.5-1years duration, 44% (7/16) ofl-5 years duration and 13% (2/16) of patients with > 5 years duration.
ICA titres in Type 1 diabetes
In the present study, the ICAtitres in 52 Type 1 diabetic patients were 80 x in 4 patients, 40 x in 2, 20 x in 6, 10 x in 3, less than 10 x in 11, and negative in 26 patients. In these 52 Type 1 diabetic patients, ICAtitres display an inverse relationship to the morbid period of diabetes (r: -0.28, n= 52, p< 0.05, t-test). Figure 5 shows serial changes of ICA titres over a follow-up period of 0.5 years in a group of Type 1 diabetic patients whose onset of disease was less than 2 years. Even during this relatively short period of follow-up, 0.5 years, ICA titres decreased or became negative in approximately 50% of the patients.
Discussion
Using the IF method, we were able to detect ICA in pancreatic tissues obtained from a relatively young blood group 0 donor (37-year-old male). However, pancreatic tissues of blood group A, B and AB patients resulted in immunofluorescence of acinar cells which interfered with the detection of ICA, as previously described [6, 10, 19] . Moreover, pancreatic tissues from elderly patients had lipofuscin within cells which interfered with the detection of ICA. In addition, since the sensitivity of ICA determination using the IF method is dependent upon the pancreas [19] , some pancreatic tissues underestimated the presence of ICA.
Using the POPA method, any human pancreatic tissues could be used for the detection of ICA regardless of age and blood type (Fig. 1, Table 1 ). In addition, the presence of acinar cells and lipofuscin did not interfere with the detection of ICA. These results indicate that POPA is useful for the detection of ICA because any human pancreas can be used regardless of age and blood type, and the staining procedures are simple and the results are highly reproducible. Furthermore, the sections can be stored for more than 5 years.
In the present study, the incidence of ICA in Type 1 diabetic patients was 50% (26/52), which is similar to previous reports [10] [11] [12] [13] [14] [15] [16] . In the recent onset diabetic patients, however, our results on the incidence in patients with less than 1 year duration are higher than those previously reported in Japanese Type I diabetes [17, 18] . Since the sensitivity by the POPA method did not differ greatly from that by the IF method, the difference of the prevalence rate may be due to the careful selection of patients. Indeed, all patients studied in the Nagasaki Prefecture, and it was not difficult to obtain the exact history of these patients.
Furthermore, we examined ICAtitres in diabetic patients with various durations of disease from the onset. ICAtitres were higher at short durations and diminished with increasing durations as previously described [15] . These results suggest that ICA titres as well as ICA positive incidence rate are inversely related to the mobid period of diabetes. However, in some patients with Type I diabetes, ICA titres were persistent and continued to be high. It appears there may be at least two types of Type 1 diabetes.
In conclusion, we have developed a new method using peroxidase-labeled protein A (POPA) for the detection of ICA. The present method is very useful because (1) the staining procedures are simple and the results are highly reproducible, (2) sections can be stored for more than 5 years and (3) any human pancreas can be used regardless of age and blood type. In addition, we found that ICA was present in all of Type i diabetic patients studied with less than 0.5 years from the onset of disease by using this sensitive and specific method for detecting ICA.
